Stocks · Healthcare · Medical - Diagnostics & Research
Biodesix, Inc. BDSX
$27.72 +1.43% Close, Oct 2, 2026 · NASDAQ · Market cap $225.6M
Strong growthStrong trend
Next earnings report: Nov 2, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -20.0% from -44.4% a year earlier.
- The diluted share count rose 40.4% in a year.
- Over the past year the stock returned +261.4%, ahead of the S&P 500 by 246.3 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 22%
- Revenue growth, 3-year CAGRTop 20%
- Revenue growth accelerationTop 17%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 46%
- Gross marginTop 28%
- Operating marginBottom 43%
- Accruals (lower is better)Top 41%
- Interest coverBottom 48%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 43%
- Free-cash-flow yieldBottom 39%
- EBITDA / enterprise valueBottom 49%
- Sales / enterprise valueTop 33%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 5%
- 6-month returnTop 12%
- 1-year return vs S&P 500Top 4%
- Distance from 52-week highTop 21%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 17%
- Consecutive EPS beatsTop 19%
- Share of analysts rating BuyTop 31%
- Upside to consensus price targetBottom 32%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 26%
- Maximum drawdown, 3 yearsBottom 17%
- Beta vs S&P 500 (lower is better)Top 8%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 29.1% | 34.5% | ↑ |
| Gross margin | 78.8% | 82.5% | ↑ |
| Operating margin | -44.4% | -20.0% | ↑ |
| FCF margin | -40.9% | -19.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 34.5% | 29.1% | ↑ | Top 22% |
| Gross margin | 82.5% | 78.8% | ↑ | Top 28% |
| Operating margin | -20.0% | -44.4% | ↑ | Bottom 43% |
| Net margin | -27.0% | -53.7% | ↑ | — |
| Free-cash-flow margin | -19.8% | -40.9% | ↑ | — |
| Return on invested capital | -25.2% | — | Bottom 46% | |
| Revenue growth, 3-year CAGR | 32.3% | — | Top 20% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -8.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -10.8 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -2.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -14.07%
- Shareholder yield
- -14.07%
- Share count change, 1 year
- +40.4%
- Share count change, 3-year CAGR
- +37.9%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 4
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +34.5%
- Average 2-day reaction, last 8
- -1.8%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $35.00
- Target vs current price
- +26.3%
- Analysts with a rating
- 8
- Share rating Buy or Strong Buy
- 88%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +21.3% | +0.1% | +6.8% | +10.1% | — |
| May 4, 2026 | +35.7% | +1.7% | +38.3% | +37.8% | +83.9% |
| Feb 26, 2026 | +53.3% | +10.0% | +18.3% | +17.2% | +17.4% |
| Nov 3, 2025 | +27.5% | -7.2% | +13.2% | +14.1% | +41.4% |
| Aug 7, 2025 | -14.3% | +14.6% | -1.7% | +13.7% | -15.8% |
| May 13, 2025 | -14.6% | -0.1% | -16.3% | -8.2% | +24.3% |
| Mar 3, 2025 | -1614.3% | -10.1% | +8.7% | -15.5% | -56.3% |
| Nov 1, 2024 | +4.3% | -23.5% | -21.8% | -15.3% | -38.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.71 | -$0.90 | +21.3% | $26.9M |
| May 4, 2026 | -$0.81 | -$1.26 | +35.7% | $25.6M |
| Feb 26, 2026 | -$0.49 | -$1.05 | +53.3% | $28.8M |
| Nov 3, 2025 | -$1.16 | -$1.60 | +27.5% | $21.8M |
| Aug 7, 2025 | -$1.60 | -$1.40 | -14.3% | $20.0M |
| May 13, 2025 | -$1.60 | -$1.40 | -14.6% | $18.0M |
| Mar 3, 2025 | -$1.20 | -$0.07 | -1614.3% | $20.4M |
| Nov 1, 2024 | -$1.40 | -$1.46 | +4.3% | $18.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 2.60× | — | — | Top 33% |
| Free-cash-flow yield | -9.04% | — | — | Bottom 39% |
| Earnings yield | -11.44% | — | — | Bottom 43% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 94
- Days above the 200-day average
- 183
- 50-day average slope (20 days)
- +11.5%
- 200-day average slope (20 days)
- +13.8%
- Distance from 50-day average
- +7.3%
- Distance from 200-day average
- +63.8%
- RSI (14)
- 50.3
- Relative volume
- 1.32×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 71.7%
- Volatility vs own 5-year history
- 17th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.29
- Correlation with S&P 500
- 0.04
- Current drawdown from 1-year high
- -9.4%
- Maximum drawdown, 3 years
- -89.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 20, 2021 | May 14, 2025 | -99.3% | 1084 days | Not yet recovered |
| Nov 3, 2020 | Nov 9, 2020 | -21.3% | 4 days | 5 days (Nov 16, 2020) |
| Nov 25, 2020 | Dec 7, 2020 | -19.8% | 7 days | 11 days (Dec 22, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $225.6M
- EPS, diluted (TTM)
- -$3.17
- Revenue (TTM)
- $102.9M
- 52-week range
- $5.26 – $31.97
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $54.5M | $38.2M | $49.1M | $71.3M | $88.5M |
| Gross profit | $24.0M | $24.1M | $36.1M | $55.8M | $71.8M |
| Operating income | -$40.9M | -$50.6M | -$41.3M | -$34.5M | -$27.8M |
| Net income | -$43.2M | -$65.4M | -$52.1M | -$42.9M | -$35.3M |
| EPS (diluted) | -$31.54 | -$31.09 | -$12.70 | -$6.62 | -$4.67 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.2M | $20.4M | $18.0M | $20.0M | $21.8M | $28.8M | $25.6M | $26.9M |
| Net income | -$10.3M | -$8.3M | -$11.1M | -$11.5M | -$8.7M | -$4.0M | -$7.8M | -$7.3M |
| EPS (diluted) | -$1.40 | -$1.13 | -$1.51 | -$1.56 | -$1.16 | -$0.49 | -$0.81 | -$0.71 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$28.2M | -$45.0M | -$22.9M | -$48.6M | -$23.3M |
| Capital expenditure | -$2.5M | -$3.5M | -$23.1M | -$3.2M | -$403,000 |
| Free cash flow | -$30.8M | -$48.5M | -$45.9M | -$51.9M | -$23.7M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $16.3M | $59.5M | $28.1M | $55.6M | $7.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $30.0M
- Total assets
- $95.3M
- Total liabilities
- $86.2M
- Total debt
- $71.8M
- Net debt
- $41.8M
- Shareholders’ equity
- $9.1M
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 214,006
- Days to cover
- 3.29
- Change vs previous report
- -2.9%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Sep 15, 2025
- 1-for-20